Preparation and Characterization of Meloxicam–Myrj-52 Granules Obtained by Melt Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Preparation and Characterization of Meloxicam–Myrj-52 Granules Obtained by Melt Granulation
Various manufacturing techniques can improve a drug's solubility, thus increasing its bioavailability. The authors examined whether melt granulation can enhance drug solubility using meloxicam as the drug substance and myrj-52 as the binder.


Pharmaceutical Technology


Pure meloxicam has a low dissolution profile. The percentage of drug dissolved in 50 min is 38.5%. Formation of PM improves this value. On the other hand, the profiles of MG and SD show a great increase in drug dissolution compared with the profiles of pure meloxicam. Reults showed that 80.2% and 90.40% of drug dissolved during the first 15 min in MG and SD prepared with myrj-52, respectively.

The dissolution enhancement can be attributed to the solubilization effect of myrj-52 and improved wettability and dispersibility of the drug from MG as well as SD (14).


Figure 9: Dissolution profile of melt granules (MG) prepared with myrj-52 after storage at 30 C and 60% relative humidity for 3 months.
The sample mixture of the components also improves the release of meloxicam, thus suggesting that melt granulation using myrj-52 could be a useful method to improve the dissolution rate of meloxicam.


Figure 10: Permeation profile of meloxicam through hairless mouse skin from saturated solution of pure meloxicam and melt granules (MG) in myrj-52.
Stability studies. To evaluate the stability of the granules, in vitro dissolution tests and X-ray analysis were performed on the samples after three months at 30 C and 60% RH (see Figure 9). The dissolution profiles of the melt granules stored for three months were similar to those of freshly prepared ones. In addition, the authors found no difference in the X-ray graph. These results suggest the physical stability of the samples, at least for the examined time.


Table IV: Permeation rate and permeation coefficient of meloxicam through hairless mouse skin.
Permeation study. Figure 10 shows the total amount of drug permeated (μg/cm2 ) through the hairless mice skin during 360 min. The permeation profiles for individual data were linear, and R ranged from 0.970 to 0.999. The results indicated that the hairless mouse skin was permeable to meloxicam and that the percutaneous absorption might be described by zero-order kinetics during the time of the study. The permeation rate of the drug from its saturated solution, in phosphate buffer (pH 7.4), across the membrane was calculated from the slope of the graph as μg.cm–2 h–1 (see Table IV).

The higher permeation rate could be attributed to the increased solubility of meloxicam. Thus, the increased drug availability at the surface of the mice skin formed a concentration gradient.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality
Source: Pharmaceutical Technology,
Click here